GET THE APP

Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 20 3868 9735

PR Raghavan

PR Raghavan

Nanorx Inc, Chappaqua, Newyork
Tanzania

Publications
  • Research Article
    Metadichol® and Healthy Skin: One Approach many Possible Cures
    Author(s): PR RaghavanPR Raghavan

    Metadichol® a nano formulation of long-chain lipid alcohols derived from food. It is an inverse agonist of Vitamin D Receptor (VDR), Aryl Hydrocarbon Receptor (AHR), and Ror Game (RORC) that could have beneficial effects on skin diseases. We now present case studies of patents with various skin disease show Metadichol is an inverse agonist of these nuclear receptors thus modulating Th1 pathway towards a TH2 and Th 17 and IL 17 and IL22 and also being a TNF alpha inhibitor can modulate IL23 thus blocking the major pathways that exacerbate many Skin diseases. Metadichol is the first molecule successfully navigates around the problems involved with promiscuous ligands and targets. It fulfils the goals of the emerging field of Poly pharmacology, i.e. a single drug is able to bind to multiple targets beyond the “one drug, one target” philosophy. We show how Metadicho.. Read More»
    DOI: 10.4172/2155-9554.1000445

    Abstract PDF

Relevant Topics